US drug spending

Smoking Drugs: Medicare Part D Spending

What Medicare Part D spent on the medicines used for this topic, how many people used them, and the cost per unit.

Each number has its full source under its own list below.

Medicare Part D spending

3 medicines (calendar year 2024). Medicines whose FDA label lists a use on this topic, by what Part D spent on them in total. Many medicines have more than one use, so the totals are not added up.

At the source
  1. 1Varenicline TartrateVarenicline Tartrate · $3.50 per unit$132.5 million
  2. 2TyrvayaVarenicline Tartrate · $76.54 per unit$71.7 million
  3. 3ChantixVarenicline Tartrate · $8.13 per unit$9,885

Source: Centers for Medicare & Medicaid Services, Medicare Part D Spending by Drug, calendar year 2024. Retrieved 12 Nov 2026.

Benchmarks on smoking

Countries side by side on public measures for this topic.

All benchmarks

Market reports on smoking

Search all
Public Health

Chronic Obstructive Pulmonary Disease (COPD) Public Health Report

Worldwide · 2024–2034

View report Pharmaceuticals

COPD Treatment

Worldwide · 2024–2034

View report Public Health

E-Cigarettes and Youth Vaping Public Health Report

Worldwide · 2024–2034

View report Public Health

Lung Cancer Public Health Report

Worldwide · 2024–2034

View report Public Health

Oral Cancer Public Health Report

Worldwide · 2024–2034

View report Public Health

Smokeless Tobacco Public Health Report

Worldwide · 2024–2034

View report

From our blog

All stories

Asthma and COPD: Breathing Easier with New Treatments

COPD is the third leading cause of death worldwide. With asthma, chronic lung disease affects hundreds of…

Read

US drug spending on related topics

All topics

Acuitas market sizes and forecasts are only in our full reports. How we use public data.